DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Neurocrine Biosciences' CEO Hosts Announcement of Positive Results of VMAT2 Inhibitor NBI-98854 in K

Neurocrine Biosciences' CEO Hosts Announcement of Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study Conference (Transcript)

Neurocrine Biosciences' CEO Presents at Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 St

Neurocrine Biosciences' CEO Presents at Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study Conference (Transcript)

Why Neurocrine Biosciences, Epizyme, and Plug Power Are Today's 3 Best Stocks

The S&P 500 delivers its first gain of the year while Neurocrine Biosciences, Epizyme, and Plug Power all rocket higher by at least 39%!

Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls on Citron Report

Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls on Citron Report

Why Epizyme, Neurocrine Biosciences, and Peregrine Soared

These 3 biotechs could beat the broader market this year.

Why Neurocrine Biosciences (NBIX) Is Spiking Today

Why Neurocrine Biosciences Inc. Shares Skyrocketed

Neurocrine shows short-minded investors why bailing during dose-escalation studies wasn't the smartest idea.

Mid-Morning Market Update: Markets Open Higher; IHS Profit Beats Estimates

Mid-Morning Market Update: Markets Open Higher; IHS Profit Beats Estimates

See More Articles...